EMERGENCY PERMIT FOR TREATMENT OF HAZARDOUS WATE, GILEAD SCIENCES, INC., LA VERNE, CALIFORNIA
Summary
SCH Number
2019100377
Public Agency
California Department of Toxic Substances Control
(DTSC)
Document Title
EMERGENCY PERMIT FOR TREATMENT OF HAZARDOUS WATE, GILEAD SCIENCES, INC., LA VERNE, CALIFORNIA
Document Type
NOE - Notice of Exemption
Received
Posted
10/21/2019
Document Description
The California Department of Toxic Substances Control (DTSC), pursuant to authority granted under California Code of Regulations, Title 22, Division 4.5, Chapter 20, Section 66270.61, has issued an Emergency Permit to Gilead Sciences, Inc., (EPA ID# CAR000265124) to treat hazardous waste through a controlled reaction with a chemical solution prior to shipment off-site to a permitted treatment, storage, and disposal facility. Specifically, two 1-Liter containers of 1,4 Dioxane, four 4-Liter containers and two 1-Liter containers of Diethyl Ether must be treated. No alternative treatment to controlled chemical reaction is available.
Contact Information
Name
Matthew Mullinax
Agency Name
Department of Toxic Substances Control Permitting Division
Contact Types
Lead/Public Agency
Phone
Name
Agency Name
Scott Petlick, Senior Environmental Health & Safetv Director, Gilead Sciences, Inc.
Contact Types
Project Applicant
Location
Cities
La Verne
Counties
Los Angeles
Notice of Exemption
Exempt Status
Emergency Project
Type, Section or Code
Sec. 21080(b)(4); 15269(b)(c)
Reasons for Exemption
This action is necessary to prevent an emergency Chemical stabilization of the 1,4 Dioxane and Diethyl Ether is necessary prior to transportation to a permitted treatment, storage, and disposal facility to prevent accidental fire and/or explosion during transport.
Attachments
Notice of Exemption
Disclaimer: The Governor’s Office of Planning and Research (OPR) accepts no responsibility for the content or accessibility of these documents. To obtain an attachment in a different format, please contact the lead agency at the contact information listed above. For more information, please visit OPR’s Accessibility Site.